Literature DB >> 3044341

Efficient expression system for human antithrombin III in baby hamster kidney cells.

G Zettlmeissl1, M Wirth, H Hauser, H A Küpper.   

Abstract

A DNA fragment carrying the enhancer of an immediate early gene of human cytomegalovirus (hCMV) was tested as a transcriptional control element by fusion downstream of a transcription unit for human antithrombin III (AT III) driven by the Simian virus (SV40) enhancer and promoter. Measurement of transient AT III expression in baby hamster kidney cells (BHK) shows that by the presence of the hCMV enhancer the synthesis of AT III is increased considerably (three to fourfold). The AT III expression vectors carrying the hCMV enhancer were used to establish stable BHK cell-lines by a new and fast G418/methotrexate selection protocol, which express up to 12 micrograms AT III/10(6) cells/24h after 40-50 days. The given system might be generally useful for the fast expression of recombinant proteins in mammalian cells, e.g. the screening of altered AT III molecules obtained by site directed mutagenesis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044341

Source DB:  PubMed          Journal:  Behring Inst Mitt        ISSN: 0301-0457


  7 in total

1.  Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.

Authors:  I Björk; K Ylinenjärvi; S T Olson; P Hermentin; H S Conradt; G Zettlmeissl
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

2.  Production of recombinant h-AT III with mammalian cell cultures using capillary electrophoresis for product monitoring.

Authors:  R Freitag; O W Reif; R Weidemann; G Kretzmer
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  A CD 4: immunoglobulin fusion protein with antiviral effects against HIV.

Authors:  J P Gregersen; S Mehdi; H Gelderblom; G Zettlmeissl
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.

Authors:  Daniel J D Johnson; Wei Li; Ty E Adams; James A Huntington
Journal:  EMBO J       Date:  2006-04-13       Impact factor: 11.598

5.  Repeated batch cultivation of rBHK cells on Cytodex 3 microcarriers: antithrombin III, amino acid, and fatty acid metabolic quotients.

Authors:  G Schmid; H Zilg; R Johannsen
Journal:  Appl Microbiol Biotechnol       Date:  1992-12       Impact factor: 4.813

6.  Antiviral effects of different CD4-immunoglobulin constructs against HIV-1 and SIV: immunological characterization, pharmacokinetic data and in vivo experiments.

Authors:  K D Langner; M Niedrig; P Fultz; D Anderson; G Reiner; H Repke; H Gelderblom; B Seed; J Hilfenhaus; G Zettlmeissl
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Efficient single step chromatographic purification of recombinant human antithrombin (rhAT) from Saccharomyces cerevisiae.

Authors:  Maheswara Reddy Mallu; Sandeep Vemula; Srinivasa Reddy Ronda
Journal:  3 Biotech       Date:  2016-05-17       Impact factor: 2.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.